Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says - The Wall Street Journal

  1. Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says  The Wall Street Journal
  2. Regeneron's antibody drug shows protection against COVID-19 for up to 8 months  Yahoo! Voices
  3. Regeneron reports COVID-19 antibody cocktail reduced infection risk by 82% for 8 months — so far  Fox News
  4. Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show  CBS Miami
  5. Regeneron says antibody cocktail cuts COVID-19 risk for up to eight months | TheHill  The Hill


source https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvcmVnZW5lcm9ucy1hbnRpYm9keS1kcnVnLWN1dC1yaXNrLW9mLWNvdmlkLTE5LWJ5LTgyLWNvbXBhbnktc2F5cy0xMTYzNjM4NTQ1OdIBAA?oc=5

Comments

Popular Posts